argenx SE
ARGX
928.44
-2.08
-0.22%
argenx SE
US · ARGX
#369 by market cap
Listed 2017
928.44
-2.08
-0.22%
Live - 5344 symbols - heartbeat 559s ago
· 2026-10-08 06:49
Pre-market
797.00
-14.16%
After-hours
928.44
0.00%
Overnight
780.55
-15.93%
- Market cap
- 58.39B
- P/E (TTM)i
- 35.37
- P/Bi
- 6.94
- EPSi
- 19.57
- Div yieldi
- 0.00%
- 52W posi
- 65%
Reader sentiment
Are you bullish or bearish on ARGX?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 20 analysts
Buy
Avg price target
1,180.78 +27.2%
Price target rangecurrent 928.44
Low932.00
Avg1,180.78
High1,415.00
Buy 95%
Hold 5%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-29 | BofA Securities | -- | BUY | -- |
| 2026-09-21 | BofA Securities | -- | BUY | 1,136.00 |
| 2026-09-17 | BofA Securities | -- | BUY | 1,136.00 |
| 2026-09-16 | BofA Securities | -- | BUY | 1,136.00 |
| 2026-09-03 | Wedbush | -- | BUY | 1,150.00 |
| 2026-09-02 | William Blair | -- | BUY | -- |
| 2026-09-01 | Morgan Stanley | -- | BUY | 1,250.00 |
| 2026-08-31 | Morgan Stanley | -- | BUY | 1,250.00 |
| 2026-08-26 | Wells Fargo | -- | BUY | 1,415.00 |
| 2026-08-26 | UBS | -- | BUY | 1,400.00 |
| 2026-08-24 | H.C. Wainwright | -- | BUY | 1,202.00 |
| 2026-08-18 | Truist Financial | -- | BUY | 1,095.00 |
| 2026-08-18 | Wedbush | -- | BUY | 1,150.00 |
| 2026-08-18 | Citizens JMP | -- | BUY | 1,200.00 |
| 2026-08-18 | Morgan Stanley | -- | BUY | 1,230.00 |
| 2026-08-18 | Citi | -- | BUY | 1,301.00 |
| 2026-08-18 | H.C. Wainwright | -- | BUY | 1,202.00 |
| 2026-08-18 | Oppenheimer | -- | BUY | 1,100.00 |
| 2026-08-17 | TD Cowen | -- | BUY | 1,353.00 |
| 2026-08-17 | William Blair | -- | BUY | -- |
| 2026-08-17 | Piper Sandler | -- | BUY | 1,215.00 |
| 2026-08-17 | BofA Securities | -- | BUY | 1,136.00 |
| 2026-08-17 | RBC Capital | -- | BUY | 1,100.00 |
| 2026-08-06 | UBS | -- | HOLD | 960.00 |
| 2026-08-04 | Guggenheim | -- | BUY | 1,185.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
A+
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1 1
■ Upgrades■ Downgrades
- 1 upgrade vs 1 downgrade among tracked analyst rating changes.
- Most recent: UBS moved from Hold to Buy on 2026-08-26.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-26 | UBS | HOLD → BUY | 1,400.00 |
| 2026-02-27 | Baird | BUY → HOLD | 867.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-22 | -- | -- | -- |
| 2026/Q2 | 2026-07-23 | -- | ±8.72% | +8.56% (in line) |
| 2026/Q1 | 2026-05-07 | -- | ±6.06% | -2.51% (in line) |
| 2025/Q4 | 2026-02-26 | -- | ±8.07% | -5.56% (in line) |
| 2025/Q3 | 2025-10-30 | -- | ±8.66% | -0.20% (in line) |
| 2025/Q2 | 2025-07-31 | -- | ±8.44% | +11.93% (beat) |
| 2025/Q1 | 2025-05-08 | -- | ±6.39% | -8.64% (beat) |
| 2024/Q4 | 2025-02-27 | -- | ±10.92% | +0.27% (in line) |
| 2024/Q3 | 2024-10-31 | -- | ±7.69% | +6.27% (in line) |
| 2024/Q2 | 2024-07-25 | -- | ±9.00% | +4.73% (in line) |
| 2024/Q1 | 2024-05-09 | -- | ±5.44% | -0.91% (in line) |
| 2023/Q4 | 2024-02-29 | -- | ±7.66% | -4.45% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 06:49:49 · For reference only, not investment advice and not tailored to your situation.